ArticleFrontiers in psychology2024
Psychometric properties and validation of the metacognitive self-assessment scale (MSAS) in a Turkish sample.
Article in Frontiers in psychology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Exploring the Link Between Metacognitive Skills with Psychological Resilience and Post-Traumatic Growth in Cancer Survivors.Journal of clinical psychology in medical settings · 2026Article
- Turkish adaptation study of the Metacognition Assessment Scale-Abbreviated in psychotic disorders.Frontiers in psychology · 2026Article
- Metacognition and Personality Functioning Levels as Mediators Between Maladaptive Personality Traits and Risk of Gambling Problems in a Non-Clinical Sample.Clinical neuropsychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Metacognition, a multifaceted psychological construct, encompasses recognising and explaining one's cognitive processes and those of others. Notably, deficits in metacognitive abilities are linked with diminished social performance, reduced quality of life, and increased severity of Personality Disorders (PD). While there are other assessment tools available in Turkish for evaluating metacognition, none offer the same combination of speed, simplicity, flexibility, and multidimensionality for screening metacognitive abilities as the Metacognition Self-Assessment Scale (MSAS).The Metacognitive Self-Assessment Scale (MSAS) was designed to evaluate various metacognitive functions-namely, Monitoring, Integration, Differentiation, and Disintegration-as described by the Metacognitive Multifunction Model. This study aims to translate and validate the MSAS for Turkish culture. Method: To check the factor structure's suitability for the Turkish population, 467 non-clinical participants (67.7% female, ranged from 18 to 31, mean 24.18; ±3.25) were included. Results: Initial analyses confirm that the scale is a valid and dependable instrument for Turkish culture. Construct validity, represented by the 18 items and four subscales, was confirmed through Confirmatory Factor Analysis (CFA) and criterion validity assessments. As well as the test-retest reliability of the scale was confirmed. Based on these findings, it was concluded that the scale is valid and reliable for use in Turkey. The model aligns well with empirical data, highlighting its strong construct validity and indicating good reliability of the scale. Conclusion: The Turkish version of the MSAS, developed to measure metacognition and its associated components, has proven to be a credible and reliable tool, especially in non-clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.